At Jenner Law, we are committed to holding companies accountable when they fail to prioritize the safety and well-being of their customers. One of the most troubling issues we are currently addressing involves the Cartiva Synthetic Cartilage Implant (SCI), a medical device that has caused harm to many patients. Recently, Jenner Law, in partnership with Alex Davis Law, filed a significant products liability lawsuit against Cartiva, Inc. and its associated entities in the United States District Court for the District of Maryland. The lawsuit was filed on behalf of a Maryland resident who suffered severe harm from the Cartiva SCI, highlighting the troubling failure of this medical device.
The Cartiva SCI: A Defective Product
The Cartiva Synthetic Cartilage Implant was marketed as a minimally invasive alternative to toe fusion for patients suffering from arthritis in their big toes. Initially, it seemed promising—a way to avoid the pain and long recovery time associated with traditional surgery. However, as more patients began receiving the implants, it became clear that the device had serious defects.
Independent studies have revealed that the Cartiva SCI failed in about two-thirds of patients. The defects include implant shrinkage, loosening, and migration—all of which can result in excruciating pain, bone loss, and the need for costly and painful revision surgeries. Despite these concerning findings, Cartiva continued to sell the implant until it was eventually recalled on October 31, 2024.
The recall was prompted by an alarmingly high failure rate, yet the lawsuit argues that Cartiva had known about these defects for years but failed to act to protect patients. Robert Connor, a resident of Chevy Chase, Maryland, is one of the individuals who suffered as a result of Cartiva’s negligence. His case underscores the larger issue at play: Cartiva allegedly continued to market and sell a faulty product without adequately warning patients and healthcare providers of the risks.
For a free legal consultation, call,
(888) 585-2188
The Legal Allegations
The complaint filed in the District of Maryland outlines several serious claims. First, it asserts that Cartiva’s failure to disclose known defects in the SCI constitutes a violation of consumer protection laws. The company is accused of prioritizing profits over patient safety by continuing to sell a product that it knew was defective.
The lawsuit also accuses Cartiva of withholding adverse event data and failing to adequately monitor the safety and effectiveness of the device. According to the recall notice, healthcare providers were instructed to remove and quarantine any remaining implants, and to closely monitor patients for worsening symptoms. This suggests that Cartiva knew the device was unsafe long before it was officially recalled, yet chose not to act in a timely manner to prevent further harm.
“Cartiva failed to live up to its promises and put profits ahead of patient safety,” said Robert K. Jenner, founding partner of Jenner Law. “This lawsuit is about holding Cartiva accountable for the pain and suffering they’ve caused to patients who trusted their product.”
The Impact on Patients
The harm caused by the defective Cartiva SCI is not limited to physical injuries alone. The plaintiffs in this case, like many others, have had to endure the emotional and financial toll of revision surgeries and ongoing treatment. The medical costs associated with these procedures can be overwhelming, and patients often experience prolonged pain and diminished quality of life.
Lead attorney Alex Davis, of Alex Davis Law, emphasized the broader implications of the case: “Our client suffered not only from the physical harm caused by this defective implant but also from the emotional and financial toll of revision surgeries and ongoing treatment. Companies like Cartiva must be held accountable for failing to ensure the safety and effectiveness of their products.”
Click to contact our personal injury lawyers today
A Call for Accountability
The Cartiva SCI lawsuit is part of a larger movement to hold medical device manufacturers accountable for defective products that harm patients. Hundreds, if not thousands, of individuals may have been affected by the device’s failure, and Jenner Law and Alex Davis Law are committed to helping those individuals seek justice.
If you or someone you know has been affected by the Cartiva Synthetic Cartilage Implant, we urge you to seek legal advice. Holding Cartiva accountable for its actions could help bring justice to those who have suffered as a result of this defective product.
At Jenner Law, we are dedicated to standing up for patients’ rights and ensuring that companies take responsibility for their products. We will continue to fight for those whose lives have been impacted by the Cartiva SCI, and we are prepared to take action on behalf of anyone who has been harmed by this dangerous medical device.
View our press release here: https://www.marketwatch.com/press-release/jenner-law-and-alex-davis-law-announce-filing-of-landmark-lawsuit-against-cartiva-c35b84f3
For more information or to schedule a consultation, please contact Jenner Law today.
Call or text (888) 585-2188 or complete a Free Case Evaluation form